This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Asia-Pacific

  1. Over nearly 20 years, the partnerships forged through efforts to introduce JE vaccination have had an impact that goes beyond JE in the Asian and Western Pacific regions. Not only did these partnerships result in more than 300 million children being protected from JE, they also strengthened health systems across multiple countries.So, what factors led to the project’s success? How can partners use the JE project experience to inform current and future efforts to take on other health challenges? PATH and its partners have compiled five key lessons learned that they hope will inform, challenge, and inspire ongoing efforts against JE, as well as other vaccination projects, to ensure impact and sustainability.
    Published: February 2020
    Type: Resource Page
  2. Following his passing, we celebrate the generous life and world-changing contributions of Dr. M. K. Bhan.
    Published: January 2020
    Type: Article
  3. With a recent approval from the World Health Organization, this high-quality, more affordable vaccine is poised to help more countries access protection against the top cause of deadly childhood pneumonia.
    Published: December 2019
    Type: Article
  4. This fact sheet provides an overview of pneumonia and other pneumococcal diseases, including disease burden and prevention and treatment measures. It also summarizes the pneumococcal conjugate vaccine (PCV) landscape, including the addition of Serum Institute of India, Pvt., Ltd.'s PCV (PNEUMOSIL®) to the suite of World Health Organization (WHO) prequalified PCVs. Also described are the Phase 3 clinical study results that constituted the pivotal data required for WHO prequalification.
    Published: December 2019
    Type: Resource Page
  5. This milestone marks a key step toward improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low- and middle-income countries
    Published: December 2019
    Type: Press Release
  6. Following a highly successful vaccination campaign, Sindh Province turns to routine immunization.
    Published: December 2019
    Type: Article
  7. A massive typhoid vaccination campaign is underway, using a new vaccine to protect kids.
    Published: December 2019
    Type: Article
  8. Published: November 2019
    Type: Press Release
  9. India continues to be one of the most populous countries on the planet and, consequently, faces immense health challenges due to its growing population. Since 1978, PATH has been working with public and private partners in India to develop local solutions, support homegrown innovation, and share our technical expertise. PATH develops, introduces, and scales up cutting-edge technologies and methodologies to tackle existing diseases and emerging health concerns. A few of our many successes in India include finding new methods to deliver nutritious food to schoolchildren, creating and implementing successful public-private partnership models to combat diseases, and expanding access to lifesaving vaccines for new mothers and their infants.
    Published: November 2019
    Type: Resource Page
  10. Published: November 2019
    Type: Article
Load more